DEFA14AThe Ballot
Enliven Therapeutics, Inc. files DEFA14A
Filed Apr 22, 2022 · 4y ago · Accession 0001193125-22-114057
Plain English
DEFA14A filed with the SEC.
Read the source below for the full document.
Filing details
- Company
- Enliven Therapeutics, Inc.
- Ticker
- ELVN
- CIK
- 1672619
- Form type
- DEFA14A
- Filing date
- Apr 22, 2022
- Report date
- —
- Document
- d273259ddefa14a.htm
- Size
- 41 KB